Safety analysis of co-administering tacrolimus and omeprazole in renal transplant recipients – A review

奥美拉唑 他克莫司 CYP3A4型 CYP2C19型 药理学 钙调神经磷酸酶 药代动力学 质子抑制剂泵 孕烷X受体 药物相互作用 肾 药物代谢 医学 化学 细胞色素P450 新陈代谢 药品 内科学 移植 生物化学 核受体 基因 转录因子
作者
Miłosz Miedziaszczyk,Ilona Idasiak-Piechocka
出处
期刊:Biomedicine & Pharmacotherapy [Elsevier BV]
卷期号:166: 115149-115149
标识
DOI:10.1016/j.biopha.2023.115149
摘要

Tacrolimus is a calcineurin inhibitor used to prevent rejection in allogenic solid organ transplant recipients, which is metabolized in the liver with cytochrome P450 isoforms 3A4 and 3A5 (CYP3A4, CYP3A5). In turn, proton pump inhibitors (PPIs), such as Omeprazole - a substrate and inhibitor of CYP2C19 and CYP3A4 enzymes - are administered to kidney transplant patients in order to prevent duodenal and gastric ulcer disease, associated with the glucocorticoid treatment. Simultaneous administration of both drugs in renal patients has the potential to trigger drug interactions. In fact, there are several mechanisms which may impact the pharmacokinetics of tacrolimus. Inhibition of the CYP2C19 isoform may suppress the metabolism of omeprazole, subsequently altering its metabolic pathway to be metabolized by the CYP3A4 enzyme in order to maintain adequate biotransformation. Therefore, the competition for CYP3A4 may affect the metabolism of tacrolimus and result in its increased plasma concentrations, as well as in adverse reactions. Another mechanism has been related to the genetic polymorphism of the CYP2C19 isoform. Since all these interactions may lead to dysfunctions of the transplanted kidney, it seems significant to eliminate their consequences, for instance via the administration of drugs which are neither substrates, nor inhibitors of the CYP3A4 enzyme. Finally, the nephrotoxic effect of omeprazole should also be accounted for. Bearing in mind the aforementioned observations, the aim of the presented paper was to review the available studies addressing the effect of omeprazole on the pharmacokinetics of tacrolimus.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
uTwTu的应助被科研通管家采纳,获得10
刚刚
打打的应助被科研通管家采纳,获得10
刚刚
刚刚
CodeCraft的应助被科研通管家采纳,获得10
刚刚
完美世界的应助被科研通管家采纳,获得10
刚刚
bkagyin的应助被科研通管家采纳,获得10
刚刚
华仔的应助被科研通管家采纳,获得10
1秒前
斯文败类的应助被科研通管家采纳,获得10
1秒前
1秒前
zouxinxin完成签到,获得积分10
2秒前
wangying完成签到 ,获得积分10
2秒前
张大旺完成签到,获得积分10
2秒前
12发布了新的文献求助10
2秒前
xucc发布了新的文献求助10
3秒前
4秒前
顺利毕业完成签到,获得积分10
4秒前
雪白的寻冬关注了科研通微信公众号
6秒前
行走的荷尔蒙的应助被依山尽采纳,获得30
7秒前
7秒前
7秒前
论文小能手完成签到 ,获得积分10
7秒前
CodeCraft的应助被冷酷成风采纳,获得10
7秒前
上官若男的应助被含糊的翠曼采纳,获得10
8秒前
8秒前
8秒前
NexusExplorer的应助被细腻驳采纳,获得10
9秒前
CipherSage的应助被SCW采纳,获得10
9秒前
11秒前
11秒前
sdl发布了新的文献求助10
12秒前
Orange的应助被li采纳,获得10
12秒前
12秒前
Liwx关注了科研通微信公众号
13秒前
13秒前
小马甲的应助被罗小黑采纳,获得10
14秒前
15秒前
Orange的应助被lili采纳,获得10
16秒前
正直未来发布了新的文献求助10
17秒前
完美世界的应助被鸭鸭采纳,获得10
17秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175157
求助须知:如何正确求助?哪些是违规求助? 9566975
关于积分的说明 21789458
捐赠科研通 7769647
什么是DOI,文献DOI怎么找? 3431836
关于科研通互助平台的介绍 2556078
邀请新用户注册赠送积分活动 2477241